Stockscreener 앱 받기
15.97
1.05%
-0.17
시간 외 거래:
15.93
-0.04
-0.25%
Kenvue Inc 주식(KVUE)의 최신 뉴스
Does the Kenvue Spinoff Signal a New Opportunity for Johnson & Johnson in 2025? - simplywall.st
Why is Kimberly-Clark hoping to acquire the embattled maker of Tylenol? - marketplace.org
Kimberly-Clark, Kenvue’s $48.7B deal among recent multibillion-dollar M&A - Manufacturing Dive
These Hedge Funds Benefit From Kenvue Deal - Institutional Investor
The Gamble Behind a Big Takeover of Tylenol’s Maker - The New York Times
Kimberly-Clark: Can The Kenvue Acquisition Erase The Decade Of Disappointment? (KMB) - Seeking Alpha
Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal - 101.3 KFDI
Kimberly-Clark acquires Kenvue for USD 48.7 billion to strengthen its leadership in personal care and health - Tissue Online North America
Kimberly-Clark CEO Mike Hsu Bets on Growth with Kenvue Deal - Business Chief
Neutrogena maker Kenvue to be sold to Kimberly-Clark in $48.7 billion deal - Cosmetics Business
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn - Yahoo Finance
Kenvue Stock Rose 12% On Possible $48.7 Billion Acquisition by Kimberly-Clark - TIKR.com
Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue - Yahoo Finance
Levin Capital Strategies L.P. Buys New Shares in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Bank of New York Mellon Corp - MarketBeat
Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal - Yahoo Finance
Kenvue Inc. $KVUE Stake Reduced by South Dakota Investment Council - MarketBeat
Kenvue: Q3 Earnings Snapshot - New Haven Register
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal - Stocktwits
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal - NPR
Is now a turning point for Kenvue Inc.Quarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Real time scanner hits for Kenvue Inc. explainedForecast Cut & AI Forecast Swing Trade Picks - newser.com
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - AOL.com
Predicting Kenvue Inc. trend using moving averages2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
21,714 Shares in Kenvue Inc. $KVUE Acquired by World Investment Advisors - MarketBeat
Kimberly-Clark to buy Kenvue - The Arkansas Democrat-Gazette
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - The Motley Fool
Will Kenvue Inc. stock outperform small cap peersJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Order flow analysis tools used on Kenvue Inc.2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
What Next for Kenvue’s Beauty Brands? - The Business of Fashion
Kenvue Fails To Deliver After Launch Expected To Drive Iconic Brands To New Heights - Citeline News & Insights
Using R and stats models for Kenvue Inc. forecastingWatch List & High Accuracy Swing Entry Alerts - newser.com
Decoding Kenvue Inc (KVUE): A Strategic SWOT Insight - GuruFocus
Kimberly-Clark is taking Tylenol in $49 billion deal - Morning Brew
Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark - Citeline News & Insights
Tylenol maker Kenvue secures deal from consumer goods giant - Yahoo Finance
Kimberly-Clark Bets $50 Billion On Health And Beauty With Kenvue Deal - Finimize
Latham Advises on Financing for Kimberly-Clark’s Acquisition of Kenvue to Create a US$32 Billion Global Health and Wellness Leader - Legal Desire Media and Insights
Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal - WQOW
Why Tylenol Maker Kenvue Stock Just Popped - AOL.com
Using RSI to spot recovery in Kenvue Inc.Trade Risk Report & Low Risk High Reward Ideas - newser.com
Kimberly-Clark is buying Tylenol maker Kenvue for more than $48 billion - qz.com
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc.KVUE - The AI Journal
Buy Rating on Kenvue, Inc.: Promising Investment Amid Acquisition and Legal Challenges - TipRanks
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient' - CNBC
Kimberly-Clark to Acquire Kenvue - WWD
North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal - Dallas Innovates
Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark - Yahoo Finance
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm - The New York Times
Factbox-Kenvue’s Legal Risks Loom Over Planned Acquisition by Kimberly-Clark - US News Money
Kimberly-Clark acquires Neutrogena-owner Kenvue - FashionNetwork USA
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - The Wall Street Journal
Markets News, Nov. 3, 2025: Dow Falters as Cloud Deals Boost Nasdaq; Kenvue Stock Soars on Kimberly-Clark Takeover - Investopedia
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Kenvue Inc. - 富途牛牛
Kenvue: Takeover by Kimberly-Clark Gives Shareholders a Lifeline - Morningstar
Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith - Yahoo Finance
Reports of ‘Click-to-Cancel’s Death May Be Premature - PYMNTS.com
Kenvue, Kimberly-Clark, Amazon, uniQure, Palantir, Idexx, Cipher Mining, and More Movers - Barron's
S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue - Investopedia
Kenvue To Be Acquired by Kimberly-Clark To Create a Personal Care Giant - Morningstar
Kimberly-Clark to Buy Tylenol Maker Kenvue. Why KMB Stock Is Tanking. - Barron's
Dear Kenvue Stock Fans, Mark Your Calendars for November 6 Upcoming earnings - Barchart.com
That $40 Billion Tylenol Deal Is Both Cheap and Risky - Bloomberg.com
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - CBS 42
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion - Bloomberg.com
The Key Question Around The Kenvue/Kimberly-Clark Tie-Up (NYSE:KVUE) - Seeking Alpha
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy - MSN
Kenvue jumps after Kimberly‑Clark announces $48.7B acquisition - Quiver Quantitative
Kenvue could see interest from other suitorsanalyst (KVUE:NYSE) - Seeking Alpha
Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger - The Guardian
Kimberly-Clark buying Tylenol-maker Kenvue in cash, stock deal worth about $48.7B - ABC7 Chicago
1.59%
0.37%
자본화:
|
볼륨(24시간):